| AML | anterior mitral leaflet |
| ASMR | atrial secondary mitral regurgitation |
| BMI | body mass index |
| CABG | coronary artery bypass grafting |
| COPD | chronic obstructive pulmonary disease |
| CPB | cardiopulmonary bypass |
| DAPT | Dual anti-platelet treatment |
| DCM | dilative cardiomyopathy |
| ESC | European society of Cardiology |
| EuroSCORE II | European System for Cardiac Operative Risk Evaluation II |
| FFP | fresh frozen plasma |
| HIV | human immunodeficiency viruses |
| ICM | ischemic cardiomyopathy |
| ICU | intensive care unit |
| IE | infective endocarditis |
| IV | intravenous |
| LA | left atrium |
| LAA | left atrial appendage |
| LV | left ventricle |
| LVEF | left ventricular ejection fraction |
| MACCE | major adverse cardiac and cerebrovascular events |
| MR | mitral regurgitation |
| MS | mitral stenosis |
| MV | mitral valve |
| MVD | mitral valve disease |
| MVr | mitral valve repair |
| MVR | mitral valve replacement |
| NOAC | new oral anticoagulants |
| PCI/PTCA | percutaneous coronary intervention/percutaneous transluminal coronary angioplasty |
| PFO | patent foramen ovale |
| PG | pressure gradient |
| PML | posterior mitral leaflet |
| PRBC | packed red blood cells |
| RA | rheumatoid arthritis |
| RCX | ramus circumflexus |
| RHD | rheumatic heart disease |
| SAPT | single anti-platelet treatment |
| sPAP | systolic pulmonary artery pressure |
| TR | tricuspid regurgitation |
| VKA | vitamin K antagonist |
| VSD | ventricular septum defect |